Frank Pallone (D-NJ)

Prohibiting Tianeptine and Other Dangerous Products Act of 2026

H.R. 7407 · House bill Health

A Democratic bill with no cosponsors

Last activity — Referred to the House Committee on Energy and Commerce.

In committee

Introduced and handed to a committee in the chamber it started in.

The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.

Its path through Congress

  1. Introduced
  2. In Committee

What this bill would do

This bill, known as the "Prohibiting Tianeptine and Other Dangerous Products Act of 2026," seeks to amend the Federal Food, Drug, and Cosmetic Act. It aims to establish new prohibited acts specifically regarding dietary supplements. The legislation introduces prohibitions on products marketed as supplements that do not meet the legal definition of a dietary supplement. It also prohibits the sale of supplements prepared or held by debarred individuals. Additionally, the bill updates import exclusion and seizure authority rules.

Yes· 3 of 6

  • Scored +6

    Does this give people more protection from unfair business practices?

    The bill enhances consumer protection by prohibiting the sale of products marketed as dietary supplements that fail to meet legal definitions.

  • Scored +5

    Does this do more about addiction and overdose deaths?

    By targeting specific dangerous products like tianeptine through stricter supplement definitions, the bill supports public health safety efforts.

  • Scored +3

    Does this make health care easier to get in general?

    The bill may indirectly improve healthcare safety by regulating the standards of dietary supplements available to the public.

The opposite

No question was scored the opposite.